Navigation Links
Study IDs benefit of donor SCT for adults with acute myeloid leukemia
Date:6/9/2009

BOSTON--A stem cell transplant (SCT) from a compatible donor early in the course of disease is the best approach for the majority of young and middle-aged adult patients with acute myeloid leukemia (AML), according to a new analysis of two dozen clinical studies.

The findings of the study, published in the June 10 issue of the Journal of the American Medical Association by researchers at Dana-Farber Cancer Institute and other institutions, provide new guidelines for treatment of the disease. For all AML patients other than the minority with "good-risk" disease, SCT from a compatible donor significantly improves survival, making it the preferred approach, the authors state.

The customary treatment for AML involves an initial "induction" phase that uses a combination of chemotherapy agents to put the disease into a first remission. The second stage of treatment, called "consolidation," is undertaken with the goal to cure the disease. Consolidation options include additional rounds of chemotherapy; autologous transplantation (which uses a patient's own blood stem cells); or allogeneic SCT (in which compatible donor cells are transplanted).

Traditionally, the treatment offered to patients has largely been based on a chromosome analysis of their AML cells. For AML with "good-risk" chromosome changes, additional chemotherapy or an autologous transplant is usually recommended. For AML with "poor-risk" changes, allogeneic SCT is usually recommended. For AML with "intermediate-risk" changes (the largest group), there has been no consensus on the best treatment.

In the new study, researchers confirmed that, consistent with current practice, patients with poor-risk AML benefited significantly from an allogeneic transplant performed in first remission, while those with good-risk disease did not benefit from the procedure. For patients with intermediate-risk disease, who account for nearly half of all adult AML patients, allogen
'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Jazz Pharmaceuticals to Present Data From First Phase III Study of Sodium Oxybate in Patients With Fibromyalgia
2. New study indicates radiologists need standards to ensure optimal visual accuracy
3. Medifocus, Inc. receives Authorization Approval from Health Canada to launch its pivotal Phase III clinical study of focused microwave heating for treatment of breast cancer in Canada
4. Results From Phase 1 Clinical Study of PEG-PAL in PKU and Update on Phase 2 Clinical Study
5. Hospital Infection Prevention Resources Cut, Study Says
6. More Ontario children are getting diagnosed with diabetes: ICES study
7. Brain Imaging Study Confirms Cognizin(R) Citicoline Boosts Mental Function; to be Presented at International Society of Sports Nutrition Annual Conference
8. Women underrepresented in cancer research, U-M study finds
9. Women under-represented in cancer research, U-M study finds
10. NEJM study points to new era in hepatitis C treatment
11. Avandia Attorney Says Study Based on Useless Trick Science
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Dennis Thompson HealthDay Reporter ... born with HIV who was thought to be cured by ... showing detectable levels of the AIDS-causing virus in her bloodstream, ... nearly 4 years old, had remained virus-free even though she ... Doctors had hoped her remission would open the door to ...
(Date:7/11/2014)... (PRWEB) July 11, 2014 The ... by Types, Applications & Geography - 2018,” defines ... fiber market with an analysis and forecast of ... specialty synthetic fibers (Para aramids, meta aramids, UHMW ... others including PPS fiber, PBI fiber, PBO fiber, ...
(Date:7/11/2014)... Operators and owners stand ... fuel costs now that model 2019 will ... standards are phasing in 2014-2018 standards. ... to install new features into their vehicles ... , 2.    Efficient driveline components which reduce friction ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap ... it comes to the summer concert schedule, it just isn’t complete ... one of the biggest names in country music and one of ... on his “That’s My Kind of Night” tour featuring Lee Brice ... making through the rest of the summer and into the fall ...
(Date:7/11/2014)... 2014 Global enterprises today are shifting ... day-to-day management activities. Managed services offer these global enterprises ... economic slowdown resulted into rising operational costs to companies. ... considered to be the global market driver for expanding ... global managed services market is estimated to grow from ...
Breaking Medicine News(10 mins):Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 2Health News:Mississippi Girl Thought Cured of HIV Shows Signs of Infection 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 2Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 3Health News:Specialty Synthetic Fibers & Glass Fiber Market Poised to Reach $20.1 Billion at a CAGR of 5.2% by 2018 – Report by MarketsandMarkets 4Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 2Health News:LeaseQ Agrees the Latest Round of Greenhouse Gas Rules Could Increase the Cost of Truck Acquisition and Maintenance 3Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 2Health News:Luke Bryan Ticket Prices Slashed at Concord Pavilion 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 2Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 3Health News:North America Managed Services Market Worth $68.65 Billion by 2018 - New Report by MicroMarket Monitor 4
... ... announcement that Newark, one of the leading electronic component distributors in the Americas, has ... , ... (PRWEB) November 17, 2009 -- NMB Technologies Corporation, a Minebea Group Company, announced today ...
... ... Seeks Users to Test, Evaluate , ... Bethesda, Md. and Northfield, Ill. (Vocus) November 17, 2009 -- The ... from SNOMED Clinical Terms® (SNOMED CT®) to the International Classification of Diseases, 9th revision, ...
... , Obesity-Attributable Health Spending to Reach ... 17 A new report ... Ken Thorpe, Ph.D., Executive Director of the Partnership to Fight Chronic ... the country will result in higher health care spending for states ...
... for the disparity need to be further explored, researchers ... without health insurance are more likely to die after ... who are insured, new research suggests. , "After ... outcomes based on insurance status," the study authors wrote. ...
... ... has been awarded this months "Editor,s Pick" by BrotherSoft in the prestigious business software ... ... desktop application has been awarded this months "Editor,s Pick" by BrotherSoft in the prestigious ...
... ... is emerging as the top business objective for employer-sponsored wellness programs around the world. ... New York ... emerging as the top business objective for employer-sponsored wellness programs around the ...
Cached Medicine News:Health News:NMB Motors Now In Stock at Newark 2Health News:U.S. National Library of Medicine Releases Draft SNOMED CT to ICD-9-CM Rules-Based Map to Support Reimbursement 2Health News:U.S. National Library of Medicine Releases Draft SNOMED CT to ICD-9-CM Rules-Based Map to Support Reimbursement 3Health News:U.S. National Library of Medicine Releases Draft SNOMED CT to ICD-9-CM Rules-Based Map to Support Reimbursement 4Health News:Obesity Rates Will Continue to Increase, Drive Health Care Costs in New Jersey in Next Decade, According to New Study 2Health News:Uninsured Trauma Patients More Likely to Die: Study 2Health News:Taskwise receives Editors Pick Award from BrotherSoft 2Health News:Taskwise receives Editors Pick Award from BrotherSoft 3Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 2Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 3Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 4Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 5Health News:Wellness Survey: Businesses Look to Wellness Programs to Improve Productivity and Lower Absenteeism Stress Cited as Top Health Risk Driving Wellness Programs Around the World 6
(Date:7/10/2014)... --  Ventana Medical Systems, Inc.  (Ventana), a member of ... an agreement with Merck KGaA, Darmstadt, Germany ... the United States and ... division on the development and commercialization of a companion ... diagnostic assays. In alignment with Merck KGaA,s strategic approach ...
(Date:7/10/2014)... , July 10, 2014   LabStyle Innovations ... Solution, today announced the appointment of Professor ... of its Board of Directors. Prof. ... business experience to LabStyle as an entrepreneur, venture ... and corporate governance expert. He currently serves on ...
(Date:7/10/2014)... 2014 Decision Resources Group finds that over ... Food and Drug Administration,s (FDA) approval of Vifor Fresenius ... was approved by the FDA in November 2013 for ... patients on dialysis. Other key findings from ... 2014 : , ...
Breaking Medicine Technology:Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 2Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 2LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 3LabStyle Innovations Welcomes Richard B. Stone to its Board of Directors 4Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... leading biopharmaceutical company dedicated to the research and development ... disorders, is marking Digestive Disease Week (DDW) 2012 in ... lives of patients with Crohn,s disease. UCB will present ... "DDW is an exciting opportunity for UCB to ...
... 17, 2012  Eisai announced today that 15 abstracts highlighting new ... Annual Meeting of the American Society of Clinical Oncology (ASCO), ... 2012. These studies highlight Eisai,s current product ... and their families affected by cancer. "Our ...
Cached Medicine Technology:UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 2UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 3UCB Proudly Reinforces Long-Standing Commitment to Crohn's Disease Community at Digestive Disease Week 2012 4Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 2Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 3Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 4Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 5Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 6Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 7Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 8Eisai Oncology to Present New Research on Product Portfolio and Pipeline at ASCO Annual Meeting 9
... ELx405 Series of microplate washers are precise, ... patented Dual-Action manifold, providing independent control of ... overfill washing and overflow protection in both ... Washer is the most precise and reliable ...
MW 96-W1 microplate washer with one wash line....
High precision microplate washer for immuno and adherent cell assays. For use with all strip types and full microplate in 96- and 384-well format in both portrait and landscape orientations....
Wellwash 384 is an efficient, rapid and reliable washing process for high-throughput screening. It has been designed to optimize the washing process and ensure the best results. Available in 384 or 9...
Medicine Products: